GTP 14564 is a cell-permeable tricyclic benzofurano-indazolo compound which functions as a specific inhibitor of class III receptor tyrosine kinases. Studies show that GTP 14564 can be used to track the signaling pathways activated by FLT3 and ITD-FLT3 in Ba/F3 cells. Furthermore, GTP 14564 can suppress the FLT3 internal tandem duplication (ITD) cells to the same extent as FLT3 siRNA. Studies show that if combined with 17-AAG, GTP 14564 can reduce the levels of p-FLT3 and p-STAT5 and can amplify apoptosis and G0/G1 arrest in FLT3-ITD cells. GTP 14564 is an inhibitor of c-Fms-CSF-1R, c-Kit, Flt-3/Flk-2 and PDGFR-beta.
1. Murata, K. et al. 2003. J. Biol. Chem. 278(35): 32892-32898. PMID: 12815052
2. Yao, Q. et al. 2005. Leukemia. 19(9): 1605-1612. PMID: 16034464
See how others have used GTP 14564 (CAS 34823-86-4). Click on the entry to view the PubMed entry .
PMID: # 30426699 Yang, L. et al. 2019. Mol. Plant Pathol. 20: 500-518.
PMID: # 20035824 Jacobi, A. et al. 2010. Exp. Hematol. 38: 180-190.
PMID: # 12815052 Murata, K. et al. 2003. J. Biol. Chem. 278: 32892-32898.